| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
8,435 |
7,702 |
$403K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
842 |
776 |
$60K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,457 |
1,406 |
$49K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,048 |
995 |
$42K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,138 |
1,943 |
$40K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,280 |
2,129 |
$23K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
665 |
630 |
$7K |
| 87807 |
|
401 |
347 |
$3K |
| 99205 |
Prolong outpt/office vis |
17 |
17 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
26 |
26 |
$2K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
207 |
194 |
$818.87 |
| 99215 |
Prolong outpt/office vis |
14 |
13 |
$499.91 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
161 |
148 |
$154.85 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
156 |
152 |
$93.74 |
| 81002 |
|
28 |
27 |
$60.04 |
| 99051 |
|
36 |
36 |
$0.00 |